Drugs in the COVID-19 Pandemic: Analysis of the Commercialization of Azithromycin, Hydroxychloroquine, Ivermectin and Nitazoxanide in Brazil. RSD 2022, 11 (6), e16711628726. https://doi.org/10.33448/rsd-v11i6.28726.